Bacterial meningitis is a severe and potentially life-threatening infection characterized by inflammation of the membranes surrounding the brain and spinal cord. This condition is primarily caused by bacteria entering the bloodstream and subsequently reaching the central nervous system. Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae are common bacterial culprits responsible for meningitis. The infection typically presents with symptoms such as severe headaches, neck stiffness, fever, and photophobia. Infants may display irritability, poor feeding, and a bulging fontanelle. Rapid diagnosis through cerebrospinal fluid analysis is crucial for effective treatment. Treatment for bacterial meningitis often involves prompt administration of intravenous antibiotics to eliminate the causative bacteria. In some cases, corticosteroids may be prescribed to reduce inflammation and minimize complications. Early intervention is essential, as delayed treatment can lead to severe neurological consequences and, in some instances, death. Prevention strategies include vaccinations against specific bacterial strains that commonly cause meningitis, such as the meningococcal and pneumococcal vaccines. Public health measures, such as maintaining good hygiene practices, also play a role in reducing the risk of bacterial meningitis transmission.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain